Intriguingly, our data point to dual mechanisms by which SPINK1 can promote ovarian cancer growth and progression: it appears to stimulate proliferation through an EGFR-dependent mechanism, while promoting resistance to anoikis through a serine protease-dependent, EGFR-independent mechanism. Here, SPINK1 is linked to ovarian carcinoma.